Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01965184 · ClinicalTrials.gov registry record · NA
Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT01965184: Completed NA study, sponsored by Yale University.
NCT01965184 is a NA study that has completed, run by Yale University. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01965184, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
This is a randomized controlled study of cognitive-behavioral therapy (CBT) for disruptive behavior such as irritability, anger and aggression in children and adolescents. CBT will be compared to Supportive Psychotherapy (SPT) and participants of this study will be randomly assigned (like the flip of a coin) to receive CBT or SPT. Participants will be also asked to complete functional magnetic resonance imaging (fMRI) and electrophysiological (EEG) tasks (recordings/images of brain activity) before and after treatment.
Primary Outcome
Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy for Anger and Aggression
- BEHAVIORAL Supportive Psychotherapy (SPT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2013-11-14 |
| Est. Completion | 2018-11-03 |
| Phase | NA |
What the finished NCT01965184 record still lists
NCT01965184 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive-Behavioral Therapy for Anger and Aggression is the first listed.
NCT01965184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01965184 about?
NCT01965184 is a clinical study titled "Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents". This is a randomized controlled study of cognitive-behavioral therapy (CBT) for disruptive behavior such as irritability, anger and aggression in children and adolescents. CBT will be compared to Supportive Psychotherapy (SPT) and participants of this study will be randomly assigned (like the flip o...
What is the current status of trial NCT01965184?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2013-11-14. Estimated completion is 2018-11-03.
What interventions are being tested in trial NCT01965184?
The interventions under investigation include: Cognitive-Behavioral Therapy for Anger and Aggression (BEHAVIORAL), Supportive Psychotherapy (SPT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01965184?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01965184's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI